PCSK9 and familial hypercholesterolemia: Gain-of-function mutations of PCSK9 cause severe hypercholesterolemia, whereas loss-of-function types lead to decreased circulating LDL cholesterol levels, protecting from cardiovascular disease (CVD) (Cohen et al., 2005).